1. Rehfeld J F, Sun G, Christensen T et al. The predominant cholecystokinin in human plasma and intestine is cholecystokinin-33. J Clin Endocrinol Metab, 2001,86(1):251–258
2. Hirata M, Itoh M, Tsuchida A et al. Cholecystokinin receptor antagonist, loxiglumide, inhibits invasiveness of human pancreatic cancer cell lines. FEBS Lett, 1996,383(3):241–244
3. Hirata M, Tsuchida A, Iwao T et al. Cholecystokinin regulates the invasiveness of human pancreatic cancer cell lines via protein kinase C pathway. Int J Oncol, 1999,14(6):1129–1135
4. Aly A, Shulkes A, Baldwin G S. Gastrins, cholecystokinins and gastrointestinal cancer. Biochim Biophys Acta, 2004,1704(1):1–10
5. Michaud D S. Epidemiology of pancreatic cancer. Minerva Chir, 2004,59(2):99–111